sponsored
PatientsVille.com Logo

PatientsVille

ABACAVIR and ARIXTRA

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectABACAVIRARIXTRA
ANAEMIA2.4% 4.6%
HAEMATOMA0% 4.4%
PYREXIA3.9% 1.7%
PULMONARY EMBOLISM0% 3.3%
DIARRHOEA3% 1%
DRUG INTERACTION2.9% 1.3%
HAEMOGLOBIN DECREASED0.7% 2.8%
HAEMORRHAGE0% 2.8%
NAUSEA2.7% 1.2%
VOMITING2.5% 1.6%
RASH2.4% 0.7%
DEATH1.8% 2.3%
OFF LABEL USE0% 2.3%
DEEP VEIN THROMBOSIS0% 2.3%
DRUG INEFFECTIVE1.2% 2%
ABDOMINAL PAIN1.8% 1.3%
DYSPNOEA1.2% 1.8%
MUSCLE HAEMORRHAGE0% 1.8%
THROMBOCYTOPENIA1% 1.7%
ASTHENIA1.7% 1%
LIPODYSTROPHY ACQUIRED1.7% 0%
MALAISE1.6% 1.1%
RENAL FAILURE ACUTE1.6% 1.1%
HEADACHE1.6% 1%
DRUG RESISTANCE1.6% 0%
INCORRECT DRUG ADMINISTRATION DURATION0% 1.6%
CEREBRAL HAEMORRHAGE0% 1.6%
FOETAL EXPOSURE DURING PREGNANCY1.6% 0%
VIROLOGIC FAILURE1.5% 0%
THROMBOSIS0% 1.5%
FATIGUE1.4% 0.8%
WEIGHT DECREASED1.4% 0.5%
PAIN IN EXTREMITY0% 1.4%
HYPERSENSITIVITY1.4% 0%
RENAL FAILURE1.3% 1%
HYPOTENSION0.7% 1.3%
OEDEMA PERIPHERAL0.5% 1.3%
SHOCK HAEMORRHAGIC0% 1.3%
IMMUNE RECONSTITUTION SYNDROME1.3% 0%
PAIN0% 1.2%
GASTROINTESTINAL HAEMORRHAGE0% 1.2%
FALL0% 1.2%
RENAL IMPAIRMENT1.2% 0%
ALANINE AMINOTRANSFERASE INCREASED1.2% 0%
MELAENA0% 1.2%
DIZZINESS1.1% 0.7%
HYPERTENSION1.1% 0.5%
MYOCARDIAL INFARCTION1.1% 0.5%
COUGH1.1% 0%
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME1.1% 0%
DRUG EXPOSURE DURING PREGNANCY1% 0.5%
NEUTROPENIA1% 0.5%
PLATELET COUNT DECREASED0.5% 1%
POST PROCEDURAL HAEMORRHAGE0% 1%
DRUG HYPERSENSITIVITY1% 0%
HYPERLIPIDAEMIA1% 0%
OVERDOSE0% 1%
ASPARTATE AMINOTRANSFERASE INCREASED1% 0%
PRURITUS0.9% 0.6%
DECREASED APPETITE0.9% 0.5%
TREATMENT FAILURE0.9% 0%
LYMPHADENOPATHY0.9% 0%
EXPOSURE DURING PREGNANCY0.9% 0%
MYALGIA0.9% 0%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.9%
HAEMATEMESIS0% 0.9%
HEPARIN-INDUCED THROMBOCYTOPENIA0% 0.9%
PRODUCT QUALITY ISSUE0% 0.9%
PNEUMONIA0.8% 0.7%
CHEST PAIN0.7% 0.8%
BLOOD CREATININE INCREASED0.8% 0.5%
SUBDURAL HAEMATOMA0% 0.8%
BLOOD ALKALINE PHOSPHATASE INCREASED0.8% 0%
JAUNDICE0.8% 0%
CONFUSIONAL STATE0% 0.8%
PREMATURE BABY0.8% 0%
ABORTION SPONTANEOUS0.8% 0%
NEUROPATHY PERIPHERAL0.8% 0%
LACTIC ACIDOSIS0.8% 0%
ARTHRALGIA0.7% 0.6%
TACHYCARDIA0.6% 0.7%
HEPATIC FUNCTION ABNORMAL0.7% 0.5%
OSTEONECROSIS0.7% 0%
HAEMATURIA0% 0.7%
RHABDOMYOLYSIS0.7% 0%
DEPRESSION0.7% 0%
MATERNAL EXPOSURE DURING PREGNANCY0.7% 0%
MITOCHONDRIAL TOXICITY0.7% 0%
GAMMA-GLUTAMYLTRANSFERASE INCREASED0.7% 0%
BLOOD BILIRUBIN INCREASED0.7% 0%
CEREBROVASCULAR ACCIDENT0% 0.7%
CONTUSION0% 0.7%
COMA0% 0.7%
EPISTAXIS0% 0.7%
PALLOR0% 0.7%
INJECTION SITE PAIN0% 0.7%
RED BLOOD CELL COUNT DECREASED0% 0.7%
SEPSIS0.6% 0.6%
BACK PAIN0.5% 0.6%
ERYTHEMA0% 0.6%
HAEMATOCRIT DECREASED0% 0.6%
INTERNATIONAL NORMALISED RATIO INCREASED0% 0.6%
DEHYDRATION0% 0.6%
INJECTION SITE HAEMATOMA0% 0.6%
RETROPERITONEAL HAEMATOMA0% 0.6%
RESPIRATORY FAILURE0% 0.6%
PLEURAL EFFUSION0% 0.6%
DIPLOPIA0.6% 0%
DIABETES MELLITUS0.6% 0%
HYPOKALAEMIA0.6% 0%
ACUTE HEPATIC FAILURE0.6% 0%
RASH MACULO-PAPULAR0.6% 0%
EYELID PTOSIS0.6% 0%
OEDEMA0.6% 0%
LIVER FUNCTION TEST ABNORMAL0.6% 0%
PANCREATITIS0.6% 0%
PROTEINURIA0.6% 0%
TREATMENT NONCOMPLIANCE0.6% 0%
PREGNANCY0.6% 0%
PANCYTOPENIA0.6% 0%
TOXICITY TO VARIOUS AGENTS0.6% 0%
METABOLIC ACIDOSIS0.6% 0%
DRUG TOXICITY0.6% 0%
NEPHROLITHIASIS0.6% 0%
LIPOATROPHY0.6% 0%
BLOOD TRIGLYCERIDES INCREASED0.6% 0%
HEPATIC ENZYME INCREASED0.6% 0%
HEPATITIS C0.6% 0%
CONDITION AGGRAVATED0.5% 0.4%
URTICARIA0% 0.5%
ASCITES0.5% 0%
HAEMORRHAGIC ANAEMIA0% 0.5%
POST PROCEDURAL HAEMATOMA0% 0.5%
INTRA-ABDOMINAL HAEMATOMA0% 0.5%
LOSS OF CONSCIOUSNESS0% 0.5%
NEOPLASM MALIGNANT0% 0.5%
SHOCK0% 0.5%
CARDIAC ARREST0% 0.5%
LIVER DISORDER0.5% 0%
VIRAL LOAD INCREASED0.5% 0%
HYPERTRIGLYCERIDAEMIA0.5% 0%
ORAL CANDIDIASIS0.5% 0%
TRANSAMINASES INCREASED0.5% 0%
CACHEXIA0.5% 0%
NERVOUS SYSTEM DISORDER0.5% 0%
ACUTE KIDNEY INJURY0.5% 0%
INSOMNIA0.5% 0%
INVESTIGATION0% 0.4%
CEREBRAL HAEMATOMA0% 0.4%
BLOOD PRESSURE DECREASED0% 0.4%
ALTERED STATE OF CONSCIOUSNESS0% 0.4%
ANXIETY0% 0.4%
MULTI-ORGAN FAILURE0% 0.4%
URINARY TRACT INFECTION0% 0.4%
ATRIAL FIBRILLATION0% 0.4%
MALIGNANT NEOPLASM PROGRESSION0% 0.4%
RECTAL HAEMORRHAGE0% 0.4%
ABDOMINAL WALL HAEMATOMA0% 0.4%
COAGULOPATHY0% 0.4%
SOMNOLENCE0% 0.4%
PLATELET COUNT INCREASED0% 0.4%

New treatments are found every day. View current ABACAVIR research studies and ARIXTRA clinical trials


Top 5 ABACAVIR Reported Side Effects

Loading...

Top 5 ARIXTRA Reported Side Effects

Loading...

Patient Forum